Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam induction dose optimization in elderly hypertensive patients
ChiCTR2500115151Phase 2Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of remimazolam in hypertension (HTN), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Hypotension after general anesthesia induction. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2500115151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115151.